Status:
COMPLETED
Post-placental Intrauterine Device Insertion During Cesarean Section
Lead Sponsor:
Assiut University
Conditions:
Intrauterine Device Migration
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy and poor perinatal outcome in a subsequent pregnancy especially in women delivered by cesarean section.The...
Eligibility Criteria
Inclusion
- Age group : 18-40 years
- Women who will be willing to undergo elective cesarean section
- women desire using Copper IUD as long acting contraceptive method.
Exclusion
- Intrauterine infection.
- Fundal Myoma.
- Hemorrhagic disorder
- Genital tract malignancy
- Uterine atony
- Sexually transmitted infection.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT03780985
Start Date
January 1 2019
End Date
April 1 2020
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Woman's Health Hospital - Assiut university
Asyut, Egypt, 71111